Sunday, June 14, 2026 Evidence-led medical research news
The First Cohort
Medical research, with the receipts

pancreatic-cancer

2 stories tagged "pancreatic-cancer"

Cancer

Pancreatic cancer's undruggable wall just cracked. The follow-up is 8.5 months and the money was already placed.

Revolution Medicines' daraxonrasib nearly doubled median overall survival versus chemotherapy in previously treated metastatic pancreatic cancer at ASCO 2026, with 8.5 months of follow-up and a two-billion-dollar Royalty Pharma deal already riding on what comes next.

Nutrition & Food

Yale's Olive Oil Cancer Story Did Not Actually Test Olive Oil

A Yale mouse study reported in Cancer Discovery is being sold as proof that olive oil fuels pancreatic cancer. The lab fed the mice purified oleic acid, the effect only showed up in males, and no one has tested it in a person.